As of today, Redeye will place its coverage of Serstech under review until further notice.
Redeye updates its estimates and valuation following Serstech’s Q3 2025 report.
Redeye provides an initial comment on Serstech’s Q3 2025 report.
Redeye updates its estimates and valuation for Serstech following the Q2 2025 report.
Redeye provides an initial comment on the Q2 2025 report from Serstech.
Redeye provides an update of its estimates and valuation for Serstech following the Q1 2025 report and our quarterly presentation with the c...
Redeye provides an initial comment on the Q1 2025 report from Serstech.
Redeye updates its estimates and valuation following Serstech's Q4 2024 report.
Redeye provides an initial comment on the Q4 2024 report from Serstech.
This morning, it was announced that Serstech is carrying out a directed share issue amounting to SEK40m before transaction costs.
Redeye provides a short comment on the recently announced SEK12.
Redeye updates its estimates and valuation following Serstech's Q3 2024 report.
Redeye provides an initial comment on the Q3 2024 report from Serstech.
Redeye provides a short comment on the announcement of two orders, totalling SEK9.
Redeye updates its estimates and valuation following Serstech's Q1 2024 report.
Redeye provides an initial comment on the Q2 2024 report from Serstech.
Redeye initiates coverage of Serstech, a rapidly growing player in the niche market for handheld Raman spectrometers.
